Investigate the Role of microRNA in Chronic Rhinosinusitis From DC-Th Axis (ITROMICRFDTA)

Chongqing Medical University

Status: Unknown

Conditions: Rhinosinusitis

Treatments: Genetic: miRNA mimics or inhibitors

Study type: Observational

Funder types: Other

Identifiers

NCT02325596

NSFC-81271061

Details and patient eligibility

About

This study aimed to evaluate the upstream events of Th17/Treg imbalance in CRS and their immune regulatory factors. Then the investigators aimed to explore the regulatory role of miRNA on DC-Th axis and its dysfunction in the pathogenesis of CRS, in order to determine the miRNA expression profile in CRS and clarify the role of miRNA in the pathogenesis of CRS by regulating the DC-Th axis.

Full description

Chronic rhinosinusitis (CRS), commonly encountered in the field of clinical otorhinolaryngology, is still a challenging proposition for doctors because of its high incidence and the unsatisfactory treatment outcomes. Nowadays, studies on the pathogenesis of NP are still attached great importance by researchers from each country. NP has become a global health problem with a considerable socioeconomic burden. Recently, research showed that the impaired balance of Th17/Treg was the significant basis of NP. Nevertheless, the pathogenesis of Th17/Treg imbalance was unclear. In this study, DC-Th axis was designed as the main line, and the regulation of miRNA on DC was designed as the entry point. This study aimed to evaluate the upstream events of Th17/Treg imbalance in CRS and their immune regulatory factors. Then the investigators aimed to explore the regulatory role of miRNA on DC-Th axis and its dysfunction in the pathogenesis of CRS, in order to determine the miRNA expression profile in CRS and clarify the role of miRNA in the pathogenesis of CRS by regulating the DC-Th axis. This study will play an important role in clarifying the pathogenesis of CRS eventually and will fill the blanks of the research between miRNA and CRS in the investigators'country. This study is with important clinical value for establishing control strategies for CRS.

Enrollment: 70 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. CRS diagnosis is accord with diagnostic criteria of The European nasal sinusitis, nasal polyps guidelines (EPOS 2012) .
2. Selected subjects are stopped using systemic or topical corticosteroids in one month before experiment.
3. All the patients have sinus CT and nasal endoscopy and allergen Skin Prick Test in preoperative.
4. Aged from 18 to 75 years old.
5. Woman or man.

Exclusion criteria

1. Choanal polyp, fungal nasal sinusitis, cystic fibrosis.
2. Acute upper respiratory tract infection and other diseases associated with the body.

Trial design

70 participants in 4 patient groups

control

Description:

Patients with only nasal septum deviation

Treatment:

Genetic: miRNA mimics or inhibitors

CRS sNP

Description:

Chronic Rhinosinusitis patients without nasal polyps

Treatment:

Genetic: miRNA mimics or inhibitors

atopic CRS wNP

Description:

Chronic Rhinosinusitis patients with allergic constitution and nasal polyps

Treatment:

Genetic: miRNA mimics or inhibitors

non-atopic CRS wNP

Description:

Chronic Rhinosinusitis patients with nasal polyps but not allergic constitution

Treatment:

Genetic: miRNA mimics or inhibitors